These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9272900)

  • 1. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine.
    McCann UD; Szabo Z; Vranesic M; Seckin E; Wand G; Duval A; Dannals RF; Ricaurte GA
    Mol Imaging Biol; 2007; 9(3):151-7. PubMed ID: 17473958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine.
    McCann UD; Eligulashvili V; Ricaurte GA
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1087-102. PubMed ID: 9829290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R; Faulds D
    Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?
    MacLean MR
    Trends Pharmacol Sci; 1999 Dec; 20(12):490-5. PubMed ID: 10603491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
    Tellier P
    Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.
    Rothman RB; Baumann MH
    Pharmacol Biochem Behav; 2002 Apr; 71(4):825-36. PubMed ID: 11888573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific and legal issues in fenfluramine/dexfenfluramine litigation.
    Poston WS; Foreyt JP
    Tex Med; 2000 Feb; 96(2):48-56. PubMed ID: 10723254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenfluramine: riddle or Rosetta stone?
    Weir EK; Obreztchikova M; Hong Z
    Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced pulmonary hypertension: must history repeat itself?
    Voelkel NF
    Pulm Pharmacol; 1996 Apr; 9(2):67-8. PubMed ID: 8880947
    [No Abstract]   [Full Text] [Related]  

  • 14. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
    Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC
    Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic drugs and pulmonary hypertension from the bedside to the bench.
    Michelakis ED; Weir EK
    Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary hypertension as a result of drug therapy.
    Higenbottam T; Laude L; Emery C; Essener M
    Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin neurotoxicity and fenfluramine and dexfenfluramine.
    O'Callaghan JP; Miller DB
    JAMA; 1997 Dec 24-31; 278(24):2141-2; author reply 2142. PubMed ID: 9417002
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic and adverse actions of serotonin transporter substrates.
    Rothman RB; Baumann MH
    Pharmacol Ther; 2002 Jul; 95(1):73-88. PubMed ID: 12163129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite suppressants and pulmonary hypertension: a long-term risk.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.